AI finds possible drug targets that major databases missed
โฎ BeforeDrug developers work from databases that disagree on which proteins sit on cell surfaces.
โ
NowAn AI approach now flags candidate surface targets that major databases overlooked.
In short
- More than 65% of approved medicines work by binding to proteins on cell surfaces.
- Major biological databases disagree about which proteins are actually found on cell surfaces.
- An AI approach flags potential surface targets that some of these databases leave out.
Why it's good news
Most approved medicines act on proteins at the cell surface, so accurate maps of those proteins matter. The major databases used to build those maps disagree, which makes drug development harder. An AI approach that flags likely surface proteins could narrow the search, though the source reports no new treatment yet.
Advertisement
From Phys.org
More than 65% of approved medicines work by binding to proteins on the surface of human cells. Yet scientists developing new treatments face a fundamental problem: Major biological databases disagree about which proteins are actually found on cell surfaces.
Ask this story
More like this
Advertisement